- Organizations: Bausch + Lomb
Pipeline
Bausch + Lomb's oral dry AMD therapy advances to clinical evaluation
Company reports a constructive meeting with the FDA over a planned trial evaluating oral tonabersat; currently eyeing a 2027 timeframe for kickoff.
Research
Real-world analysis ties enVista Aspire IOL to functional intermediate vision
Outcomes largely mirrored previous clinical findings, with most eyes achieving strong distance vision alongside functional intermediate acuity.
Business
Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Events
Bausch + Lomb debuts IOL Compass framework for premium lens decisions
One-day-only, faculty-led surgeon education program routes candidacy, lens match, and post-op care into one system.
Pipeline
Bausch + Lomb dry eye combo drop advances to phase 3 evaluation
Formulation includes active ingredients of XIIDRA and MIEBO; positive data also reported on a first-in-class drop for targeting ocular pain signaling.
Business
WaveFront Dynamics integrates B+L, Wave Eye Care scleral lenses
Offers ECPs expanded access to advanced wavefront-guided diagnostics with proprietary optic design services—plus new scleral lens offerings.
Products
Bausch + Lomb launches EyeGility Inserter preloaded IOL delivery system
With an ergonomic design, the single-use, manual surgical instrument is specifically intended for preloaded enVista Aspire and Envy IOLs.
Events
ASRS 2026: industry highlights and product innovations
Annual retina specialists meeting kicks off in Montreal with immersive, interactive experiences and technology showcases.
Products
Bausch + Lomb launches new AI-based digital health platform
Orphia will offer pre-surgery cataract education for patients via clinically-validated AI agents.
Products
Bausch + Lomb launches Blink Triple Care PF eye drops
Preservative-free lubricant features hyaluronic acid and castor oil to offer a 3-in-1 extended dry eye symptom relief for up to 10 hours.
Research
PreserVision AREDS3 launch highlights B vitamins’ potential role in AMD
Bausch + Lomb advanced PreserVision formula spotlights the unique B-vitamin complex in reducing the risk for AMD, especially in earlier stages.
Events
B+L Vision Care Summit spotlights contact lens and technology advancements
Clinicians share insights on dry eye care, contact lens adoption, and patient-centered treatment approaches.
Events
Nutritional supplementation is redefining eye health management
Highlights from Bausch + Lomb’s first-ever consumer summit.
Events
B+L Consumer Summit highlights OTC integration as key to managing ocular surface health
Clinicians emphasize over-the-counter options as a first-line treatment for ocular surface disease during Bausch + Lomb’s one-day consumer summit.
Products
FDA clears Bausch + Lomb's Bi-Blade+ vitrectomy cutter and fluidics technology
Dual-port vitrectomy cutter increases cutting speed from 15K to 25K per minute, while Adaptive Fluidics update expands capabilities of the Stellaris Elite system
Pipeline
Positive 24-month data supports the Elios System for glaucoma treatment
Microinvasive, implant-free procedure used excimer laser technology to lower IOP by 20% or greater among 76% of glaucoma and cataract patients
Research
Study: enVista Aspire IOL delivers expanded intermediate vision without sacrificing distance
Prospective study evaluates the enhanced monofocal IOL among patients undergoing standard phaco.
Business
Bausch + Lomb and Ripple Therapeutics partner to develop sustained-release implants
Collaboration involves the Epidel prodrug platform, which engineers polymer-free drugs with customized, repeat doses and durations for ophthalmic diseases.
Research
Pivotal study showcases enVista Envy IOL's full range of vision
Data includes meeting all efficacy and safety outcomes, with the lens demonstrating statistical superiority in visual outcomes and a favorable dysphotopsia profile.
Research